Skip to main content

Visit our other sites

jnj.com
jnjinnovation network
JLABS
Quickfire Challenges

Main navigation

Home
About us
Partner with us
Blog
News
Challenges
Video hub
Connect with Us

News

Maintabs

All news
Press releases
In the media
Partner news
Social
Other News

Article view
List view

Refine by

Refine by

Type

In the media
JNJ Press releases
(-) Partner news

Period

2020
2019
2018
(-) 2017
2016
2015
2014
2013
2012
2011
2010
2009
2008

Jan
Feb
Apr
Jun
Jul
Sep
Nov

Locations & regions

Focus area

Clear filters

News

1 November 2017

On Target Laboratories secures $40 million financing led by Johnson & Johnson Innovation – JJDC, Inc. (JJDC)

Read full story

25 September 2017

Fusion Pharmaceuticals Completes Oversubscribed Series A Financing Totaling $46 Million USD to Develop Targeted Alpha Therapeutics

Read full story

21 September 2017

Provention Bio Announces Licensing Agreements with Janssen for Two Clinical-Stage Immunology Assets

Read full story

Accelerator Corporation Announces Series A Financing in Rodeo Therapeutics to Focus on Small-Molecule Regenerative Therapies

Read full story

BlackThorn Therapeutics Enrolls First Patient in Phase 2a Study of Lead Compound, BTRX-246040, in Major Depressive Disorder

Read full story

E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline

Read full story

Provention Bio, Inc. Appoints Eleanor L. Ramos, MD, as Chief Medical Officer and Chief Operating Officer

Read full story

Provention Bio, Inc. Secures $28.4 Million Founding Financing to Fund Development Targeting the Interception and Prevention of Immune-Mediated Disease

Read full story

Aelix Therapeutics appoints HIV expert as CMO

Read full story

23 February 2017

FACIT-Seeded Fusion Pharmaceuticals Closes US$25M Series A Led by Johnson & Johnson Innovation

Read full story

17 February 2017

Ethicon Announces Agreement to Acquire Torax Medical, Inc.

Read full story

26 January 2017

Verb Surgical Delivers Digital Surgery Prototype Demonstration to Collaboration Partners

Read full story

BlackThorn Therapeutics Secures $14 Million in Series A Extension Financing

Read full story

Sidebar

Currently trending

Currently trending

Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)
Johnson & Johnson Announces Agreement to Acquire Remaining Stake in Verb Surgical Inc.
Zebra Medical Vision Announces Agreement With DePuy Synthes to Deploy Cloud Based Artificial Intelligence Orthopaedic Surgical Planning Tools
At the Bio-Europe conference in Hamburg last month, experts weighed in on the challenges and future of neuroscience
The science of prevention
Syndesi Therapeutics announces successful completion of first-in-human Phase I study of novel SV2A modulator, SDI-118, in development for the treatment of cognitive impairment.
Medopad And Janssen Develop Automated Digital Test To Detect Alzheimer’s Earlier
Janssen Korea Ltd. and Johnson & Johnson Innovation Announced Awardees of the Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with the Seoul Metropolitan Government and Korea Health Industry Development Institute
Janssen Korea Ltd. and Johnson & Johnson Innovation Announced Awardees of the Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with the Seoul Metropolitan Government and Korea Health Industry Development Institute
Chardan Healthcare Acquisition Corp. Completes Merger with BiomX Ltd.

Trending

Trending

Change 1 Thing, Change Everything: Improving Contact Lenses

Change 1 Thing, Change Everything: Improving Hip Replacement

Johnson & Johnson Innovation, Change One Thing, Change Everything: AdoRx